Literature DB >> 18222648

Neuropsychological predictors of functional outcome in Cognitive Behavioral Social Skills Training for older people with schizophrenia.

Eric Granholm1, John R McQuaid, Peter C Link, Scott Fish, Thomas Patterson, Dilip V Jeste.   

Abstract

Cognitive Behavioral Social Skills Training (CBSST) is a 24-session weekly group therapy intervention to improve functioning in people with schizophrenia. In our prior randomized clinical trial comparing treatment as usual (TAU) with TAU plus group CBSST (Granholm, E., McQuaid, J.R., McClure, F.S., Auslander, L., Perivoliotis, D., Pedrelli, P., Patterson, T., Jeste, D.V., 2005. A randomized controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. Am. J. Psychiatry 162, 520-529.), participants with schizophrenia in CBSST showed significantly better functional outcome than participants in TAU. The present study was a secondary analysis of neuropsychological predictors of functional outcome in our prior CBSST trial. We examined (1) whether neuropsychological impairment at baseline moderated functional outcome in CBSST relative to TAU, and (2) whether improvement in neuropsychological abilities mediated improvement in functional outcome in CBSST. Attention, verbal learning/memory, speed of processing, and executive functions were assessed at baseline, end of treatment, and 12-month follow-up. Greater severity of neuropsychological impairment at baseline predicted poorer functional outcome for both treatment groups (nonspecific predictor), but the interaction between severity of neuropsychological impairment and treatment group was not significant (no moderation). Effect sizes for the difference between treatment groups on functional outcome measures at 12-month follow-up were similar for participants with relatively mild (d=.44-.64) and severe (d=.29-.60) neuropsychological impairment. Results also did not support the hypothesis that improvement in neuropsychological abilities mediated improvement in functioning in CBSST. Adding CBSST to standard pharmacologic care, therefore, improved functioning relative to standard care alone, even for participants with severe neuropsychological impairment, and this improvement in functioning was not related to improvement in neuropsychological abilities in CBSST.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222648      PMCID: PMC2352154          DOI: 10.1016/j.schres.2007.11.032

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  42 in total

1.  Norms for letter and category fluency: demographic corrections for age, education, and ethnicity.

Authors:  J A Gladsjo; C C Schuman; J D Evans; G M Peavy; S W Miller; R K Heaton
Journal:  Assessment       Date:  1999-06

Review 2.  Conventional vs. newer antipsychotics in elderly patients.

Authors:  D V Jeste; E Rockwell; M J Harris; J B Lohr; J Lacro
Journal:  Am J Geriatr Psychiatry       Date:  1999       Impact factor: 4.105

3.  London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. II: Predictors of outcome.

Authors:  P Garety; D Fowler; E Kuipers; D Freeman; G Dunn; P Bebbington; C Hadley; S Jones
Journal:  Br J Psychiatry       Date:  1997-11       Impact factor: 9.319

4.  Cognitive and symptom correlates of participation in social skills training groups.

Authors:  M McKee; J W Hull; T E Smith
Journal:  Schizophr Res       Date:  1997-02-28       Impact factor: 4.939

5.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

6.  Cognitive predictors of skill acquisition on social problem solving in patients with schizophrenia.

Authors:  Alp Uçok; Sibel Cakir; Zekiye Cetinkaya Duman; Aysun Dişcigil; Pinar Kandemir; Hatice Atli
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

7.  Symptoms and neurocognition as rate limiters in skills training for psychotic patients.

Authors:  T E Smith; J W Hull; S Romanelli; E Fertuck; K A Weiss
Journal:  Am J Psychiatry       Date:  1999-11       Impact factor: 18.112

Review 8.  Older patients with schizophrenia: challenges in the coming decades.

Authors:  B W Palmer; S C Heaton; D V Jeste
Journal:  Psychiatr Serv       Date:  1999-09       Impact factor: 3.084

9.  Cognitive deficits and psychiatric rehabilitation outcomes in schizophrenia.

Authors:  S M Silverstein; L S Schenkel; C Valone; S W Nuernberger
Journal:  Psychiatr Q       Date:  1998

Review 10.  What are the functional consequences of neurocognitive deficits in schizophrenia?

Authors:  M F Green
Journal:  Am J Psychiatry       Date:  1996-03       Impact factor: 18.112

View more
  17 in total

1.  Stakeholder Perspectives on Implementing Cognitive Behavioral Social Skills Training on Assertive Community Treatment Teams.

Authors:  David H Sommerfeld; Gregory A Aarons; Jeanean B Naqvi; Jason Holden; Dimitri Perivoliotis; Kim T Mueser; Eric Granholm
Journal:  Adm Policy Ment Health       Date:  2019-03

2.  Social skills training and computer-assisted cognitive remediation in schizophrenia.

Authors:  Matthew M Kurtz; Kim T Mueser; Warren R Thime; Silvia Corbera; Bruce E Wexler
Journal:  Schizophr Res       Date:  2015-01-29       Impact factor: 4.939

3.  Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.

Authors:  Xiang Yang Zhang; Da Chun Chen; Mei Hong Xiu; Colin N Haile; Xingguang Luo; Ke Xu; Hui Ping Zhang; Lingjun Zuo; Zhijun Zhang; Xiangrong Zhang; Therese A Kosten; Thomas R Kosten
Journal:  Hum Genet       Date:  2012-02-24       Impact factor: 4.132

Review 4.  Neurocognition as a predictor of response to evidence-based psychosocial interventions in schizophrenia: what is the state of the evidence?

Authors:  Matthew M Kurtz
Journal:  Clin Psychol Rev       Date:  2011-02-26

5.  Memory performance predicts recurrence of mania in bipolar disorder following psychotherapy: A preliminary study.

Authors:  Isabelle E Bauer; Martin Hautzinger; Thomas D Meyer
Journal:  J Psychiatr Res       Date:  2016-10-11       Impact factor: 4.791

Review 6.  New wine in old bottle: late-life psychosis.

Authors:  Alana Iglewicz; Thomas W Meeks; Dilip V Jeste
Journal:  Psychiatr Clin North Am       Date:  2011-06

Review 7.  Antipsychotic drug treatment for elderly people with late-onset schizophrenia.

Authors:  Adib Essali; Ghassan Ali
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

8.  Neurocognitive predictors of treatment response to randomized treatment in adults with tic disorders.

Authors:  Amitai Abramovitch; Lauren S Hallion; Hannah E Reese; Douglas W Woods; Alan Peterson; John T Walkup; John Piacentini; Lawrence Scahill; Thilo Deckersbach; Sabine Wilhelm
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-11-15       Impact factor: 5.067

9.  Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive-behavioral therapy in schizophrenia.

Authors:  Veena Kumari; Emmanuelle R Peters; Dominic Fannon; Elena Antonova; Preethi Premkumar; Anantha P Anilkumar; Steven C R Williams; Elizabeth Kuipers
Journal:  Biol Psychiatry       Date:  2009-06-27       Impact factor: 13.382

10.  The impact of skills training on cognitive functioning in older people with serious mental illness.

Authors:  Sarah I Pratt; Kim T Mueser; Stephen J Bartels; Rosemarie Wolfe
Journal:  Am J Geriatr Psychiatry       Date:  2013-03       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.